Stockreport

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

GeneDx Holdings Corp. - Class A  (WGS) 
PDF Program to expand access to exome sequencing to help clinicians confirm diagnosis and guide clinical decision-making in NPC GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx [Read more]